MigraineMind research summary
Phenotype-guided selection of venlafaxine and topiramate for vestibular migraine: a narrative review.
Front Neurosci | 2026
ReviewSummary
Vestibular migraine (VM) causes recurrent vertigo and is often underdiagnosed. It has various symptoms, making diagnosis challenging. There are no validated biomarkers for VM. Recent research suggests personalized treatment strategies are better than standard approaches. Venlafaxine and topiramate are two key medications for VM prevention. Venlafaxine may help patients with anxiety, depression, or specific dizziness issues. It can also benefit those with significant emotional and functional difficulties. Topiramate might be a better choice for patients with frequent headaches or sensory sensitivity. Current studies indicate that both medications can effectively reduce vestibular symptoms. This review emphasizes the importance of tailoring treatment based on individual patient profiles. Understanding these differences can help healthcare providers choose the right medication for each patient. The goal is to improve the overall management of vestibular migraine and enhance patients' quality of life. Clinical relevance: This research highlights the need for personalized treatment strategies for vestibular migraine, which can improve outcomes for patients based on their unique symptoms and profiles.
Key Learning Points
- Vestibular migraine is often underdiagnosed due to its varied symptoms, making awareness crucial for both patients and clinicians.
- There are currently no validated biomarkers for diagnosing vestibular migraine, highlighting the need for careful clinical evaluation.
- Personalized treatment strategies are more effective than standard approaches in managing vestibular migraine symptoms.
- Venlafaxine and topiramate are effective medications for preventing vestibular migraine, but their suitability depends on individual patient profiles.
- Understanding the specific needs and symptoms of each patient can significantly enhance the management of vestibular migraine and improve quality of life.
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.